Cardiovascular Risk Reduction In Participants With Elevated Lp A clinical trials

Explore recruiting cardiovascular risk reduction in participants with elevated lp a clinical trials.

Also recruiting in Europe

Cardiovascular Risk Reduction In Participants With Elevated Lp A trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multi- center, randomized, double-blind, placebo-controlled parallel–group, dose-finding study to evaluate efficacy, safety, and tolerability of DII235 in adults with elevated Lipoprotein(a)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cardiovascular Risk Reduction In Participants With Elevated Lp A trials by city

Cardiovascular Risk Reduction In Participants With Elevated Lp A in Toronto Cardiovascular Risk Reduction In Participants With Elevated Lp A in Vancouver Cardiovascular Risk Reduction In Participants With Elevated Lp A in Montreal Cardiovascular Risk Reduction In Participants With Elevated Lp A in Calgary Cardiovascular Risk Reduction In Participants With Elevated Lp A in Edmonton Cardiovascular Risk Reduction In Participants With Elevated Lp A in Ottawa Cardiovascular Risk Reduction In Participants With Elevated Lp A in Winnipeg Cardiovascular Risk Reduction In Participants With Elevated Lp A in Quebec City Cardiovascular Risk Reduction In Participants With Elevated Lp A in Hamilton Cardiovascular Risk Reduction In Participants With Elevated Lp A in Kitchener Cardiovascular Risk Reduction In Participants With Elevated Lp A in London Cardiovascular Risk Reduction In Participants With Elevated Lp A in Halifax Cardiovascular Risk Reduction In Participants With Elevated Lp A in New York Cardiovascular Risk Reduction In Participants With Elevated Lp A in Los Angeles Cardiovascular Risk Reduction In Participants With Elevated Lp A in Chicago Cardiovascular Risk Reduction In Participants With Elevated Lp A in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease